Gambia vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Mauritania
100.0%
in 2023
Gambia rank
1st
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Mauritania
How they compare
Gambia currently reports 100.0% against 100.0% in Mauritania, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2006 it was Gambia ahead.
Gambia ranks 1st and Mauritania ranks 1st of 180 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Gambia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.0% | 3.8% | 60.2% | Gambia |
| 2010s | 54.5% | 43.1% | 11.4% | Gambia |
| 2020s | 86.8% | 100.0% | 13.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Mauritania?
- Gambia, at 100.0% against 100.0% in Mauritania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Mauritania?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mauritania?
- 10 years are reported by both, from 2006 to 2023.
- How do Gambia and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Mauritania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.